{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CREX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:51:51.126Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":11718,"canonical_name":"CREATIVE REALITIES, INC.","cik":"0001356093","uei":null,"lei":null,"duns":null,"ticker":"CREX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":15},"count":15,"timeline":[{"ts":"2026-08-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CREATIVE REALITIES, INC. — 2026-08-14","url_slug":"/sec/cik-0001356093/10-q/0001437749-26-027825","accession_number":"0001437749-26-027825","importance":45},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — CREATIVE REALITIES, INC. — 2026-08-13","url_slug":"/sec/cik-0001356093/8-k/0001437749-26-027479","accession_number":"0001437749-26-027479","importance":35},{"ts":"2026-08-10","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CREATIVE REALITIES, INC. — 2026-08-10","url_slug":"/sec/cik-0001356093/schedule-13g-a/0001437749-26-026817","accession_number":"0001437749-26-026817","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — CREATIVE REALITIES, INC. — 2026-07-02","url_slug":"/sec/cik-0001356093/4/0001437749-26-022464","accession_number":"0001437749-26-022464","importance":30},{"ts":"2026-06-30","kind":"sec.insider.p","reporter":"MILLS RICHARD C","title":"Chief Executive Officer","shares":200000,"price_per_share":3.5,"usd_value":700000,"security_title":"Common Stock","importance":50.7},{"ts":"2026-06-30","kind":"sec.insider.p","reporter":"Koshewa Tamra L","title":"Chief Financial Officer","shares":28571,"price_per_share":3.5,"usd_value":99999,"security_title":"Common Stock","importance":50.0999985},{"ts":"2026-06-29","kind":"sec.filing","form_type":"8-K","title":"8-K — CREATIVE REALITIES, INC. — 2026-06-29","url_slug":"/sec/cik-0001356093/8-k/0001437749-26-021905","accession_number":"0001437749-26-021905","importance":35},{"ts":"2026-06-29","kind":"sec.filing","form_type":"424B5","title":"424B5 — CREATIVE REALITIES, INC. — 2026-06-29","url_slug":"/sec/cik-0001356093/424b5/0001437749-26-021901","accession_number":"0001437749-26-021901","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"424B3","title":"424B3 — CREATIVE REALITIES, INC. — 2026-06-18","url_slug":"/sec/cik-0001356093/424b3/0001437749-26-021098","accession_number":"0001437749-26-021098","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — CREATIVE REALITIES, INC. — 2026-06-16","url_slug":"/sec/cik-0001356093/effect/9999999995-26-002018","accession_number":"9999999995-26-002018","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — CREATIVE REALITIES, INC. — 2026-06-11","url_slug":"/sec/cik-0001356093/corresp/0001437749-26-020338","accession_number":"0001437749-26-020338","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"UPLOAD","title":"UPLOAD — CREATIVE REALITIES, INC. — 2026-06-10","url_slug":"/sec/cik-0001356093/upload/0000000000-26-005857","accession_number":"0000000000-26-005857","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"S-3","title":"S-3 — CREATIVE REALITIES, INC. — 2026-06-04","url_slug":"/sec/cik-0001356093/s-3/0001437749-26-019569","accession_number":"0001437749-26-019569","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CREATIVE REALITIES, INC. — 2026-05-15","url_slug":"/sec/cik-0001356093/10-q/0001437749-26-017219","accession_number":"0001437749-26-017219","importance":45},{"ts":"2026-05-15","kind":"sec.filing","form_type":"8-K","title":"8-K — CREATIVE REALITIES, INC. — 2026-05-15","url_slug":"/sec/cik-0001356093/8-k/0001437749-26-017218","accession_number":"0001437749-26-017218","importance":35}]}